"This is the first study to investigate the ways in which positive...
Category:
Health
Latest
India to consider new drugs bill to regulate imports, manufacturing
India's $41 billion pharmaceutical industry is one the largest in...
New app can help identify autistic children in India: Study
Through a series of simple games, questions, images and activities...
Life and health insurance most likely products to see long-term benefits from COVID-19:GlobalData survey
Ben Carey-Evans, Analyst at GlobalData, comments: “Business interruption insurance is another product that could positively be impacted by COVID-19. Businesses around the world would have been scarred by forced closures throughout 2020 and into 2021 were they not able to operate. It is likely that the positive impact to this business line will be felt over time, as business owners would be very interested in policies that include pandemic cover. This product would likely have scored even higher had there not been disputes around whether insurers should pay out on COVID-19-related claims.”
OUTLOOK 2021: Regulatory challenges abound for U.S. insurers as Biden takes over, pandemic rages
While a major overhaul of insurance regulation has been ruled out, and Biden’s primary insurance-related focus is expected to be on healthcare, experts say life and property-and-casualty insurers will also need to prepare for an increase in regulatory attention from the new administration as it rushes to temper the impact of the COVID-19 pandemic.
Natural Covid-19 remedy-makers conduct clinical trial
“A clinical trial was conducted in India to monitor the outcome of a combination treatment for Covid. An Ayurvedic Remedy called ‘Immunofree’ by Corival Life Sciences, and a Nutraceutical called ‘Reginmune’ by Biogetica is found to work better in a comparative clinical trial against Standard of Care,” said a statement.
J&J says vaccine offers 100% protection against coronavirus deaths
J&J’s vaccine is different from the messenger RNA-based shots made by Moderna and partners Pfizer and BioNTech SE, which each were shown to be more than 90% effective.
India’s COVID response saved over 1 lakh lives: Eco Survey
The 40-day lockdown period, it said was used to scale up the necessary medical and para-medical infrastructure for active surveillance, expanded testing, contact tracing, isolation and management of cases, and educating citizens about social distancing and masks.
U.N. chief urges business to take the lead on COVID-19, climate and global recovery
“We count on businesses to play an important role by themselves and to put pressure on governments to do the right thing,” he said. “We need you more than ever to help us change course, end fragility, avert climate catastrophe and build the equitable and sustainable future we want and we need.”
India needs a healthcare regulator, will facilitate premium reduction:Economic Survey
The mitigation of information asymmetry, that will be ensured by the proposed healthcare regulator,would also help lower insurance premiums, enable the offering of better products and help increase the insurance penetration in the country,said the pre-Budget document tabled in Parliament on Friday.
Accord ”strategic sector” tag to pharma: Par panel
In its report, tabled in Parliament on Friday, on the review of loss-making central public sector enterprises, the Committee on Public Undertakings chaired by Meenakshi Lekhi observed that the indigenous awareness of healthcare facilities is of paramount importance of any nation.
The Committee said it was of the strong opinion that pharma sector plays a very important role to keep the nation healthy and strong, and this has been quite apparent during the current pandemic when the need for strong indigenous pharma companies has been realised with more intensity.
India’s Insurance penetration rises to 3.76%,density at around $78 in 2019-20:Eco Survey
As of 2019, the penetration for life insurance in India is 2.82 per cent, the penetration for non-life insurance is much at 0.94 per cent.
During 2019-20, the gross direct premium of non-lLife insurers was Rs 1.89 lakh crore, as against Rs 1.69 lakh crore in 2018-19, registering a growth of 11.45 per cent. Within non-life category, motor and health segments primarily are the main contributors to industry to report this growth.
Life insurance industry recorded a premium income of Rs 5.73 lakh crore in 2019-20 as against Rs 5.08 lakh crore in the previous financial year, registering a growth of 12.75 per cent.
While renewal premium accounted for 54.75 per cent of the total premium received by the life insurers, new business contributed the remaining 45.25 per cent
WHO launches plan to tackle neglected diseases as Covid-19 strains healthcare
By Zachary Fagenson, The World Health Organization (WHO) will on Thursday launch a plan to combat 20 diseases that affect the world's poorest people, seeking to prevent recent progress being erased by the impact of Covid-19 on healthcare...